Genomisk medicin og kræft

Our genomic understanding of cancer evolves quickly, driven by technological advances. Insights are added every day, but their interpretations are based on fundamental hypotheses on heredity and cell biology formulated more than 100 years ago. Genomic medicine is already in some use, but data from extremely large experiments of 100,000s of patients, controls, and tumours will alter the whole management of cancer; from early detection programmes before diagnosis, to efficient diagnostics, targeted treatment, response surveillance and monitoring of relapse.